Wells Fargo Maintains Overweight on Ovintiv, Lowers Price Target to $81

Benzinga · 2d ago
Wells Fargo analyst Noah Hungness maintains Ovintiv (NYSE:OVV) with a Overweight and lowers the price target from $82 to $81.